Trans-jasmonic acid (JA), cis-JA, and trans-methyl jasmonate (MeJA) were quantified in pulp and seeds of `Tsugaru' apple [Malus sylvestris (L.) Mill. var. domestica (Borkh.) Mansf.] and `Satohnishiki' sweet cherry (Prunus avium L.). Trans-JA and cis-JA showed similar changes during development in both types of fruit. JA concentration was high in the early growth stages of apple pulp development, decreased with days after full bloom (DAFB), and then increased again during maturation. There was an initial decrease in concentration of MeJA in apple pulp, followed by a general increase towards harvest. Concentrations of JA and MeJA in the pulp of sweet cherry were high during early growth stages, then decreased towards harvest. PDJ treatment at 104 DAFB (preclimacteric stage) increased endogenous abscisic acid concentration and anthocyanin concentration at 122 and 131 DAFB (maturation stages) in apple. JA concentration in apple seeds was also high in the early growth stages, then decreased, and finally peaked at harvest. MeJA concentration in apple seeds increased towards harvest. In the seeds of sweet cherry, JA and MeJA concentrations generally increased until harvest. In both types of fruit, concentrations of JA and MeJA in the seeds were higher than those of pulp. On a dry weight basis, changes in concentration in the seeds preceded those in the pulp. These results demonstrate that relatively high amounts of JA and MeJA are associated with young developing fruit. These substances may have a role in regulation of fruit growth at early growth stages, though this has not been demonstrated. Chemical name used: n-propyl dihydrojasmonate (PDJ).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.